<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with OASIS Tables with MathML3 v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-archive-oasis-article1-mathml3.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jpoasis-nisons2nlmx2.xsl?><?ConverterInfo.Version 1?><?covid-19-tdm?><front><journal-meta><journal-id journal-id-type="nlm-ta">Mol Inform</journal-id><journal-id journal-id-type="iso-abbrev">Mol Inform</journal-id><journal-id journal-id-type="doi">10.1002/(ISSN)1868-1751</journal-id><journal-id journal-id-type="publisher-id">MINF</journal-id><journal-title-group><journal-title>Molecular Informatics</journal-title></journal-title-group><issn pub-type="ppub">1868-1743</issn><issn pub-type="epub">1868-1751</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7228259</article-id><article-id pub-id-type="doi">10.1002/minf.202000028</article-id><article-id pub-id-type="publisher-id">MINF202000028</article-id><article-categories><subj-group subj-group-type="overline"><subject>Full Paper</subject></subj-group><subj-group subj-group-type="heading"><subject>Full Papers</subject></subj-group></article-categories><title-group><article-title>Rapid Identification of Potential Inhibitors of SARS&#x02010;CoV&#x02010;2 Main Protease by Deep Docking of 1.3&#x02005;Billion Compounds</article-title></title-group><contrib-group><contrib id="minf202000028-cr-0001" contrib-type="author"><name><surname>Ton</surname><given-names>Anh&#x02010;Tien</given-names></name><xref ref-type="aff" rid="minf202000028-aff-0001">
<sup>1</sup>
</xref><xref ref-type="author-notes" rid="minf202000028-note-1001">
<sup>&#x02020;</sup>
</xref></contrib><contrib id="minf202000028-cr-0002" contrib-type="author"><name><surname>Gentile</surname><given-names>Francesco</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-8299-1976</contrib-id><xref ref-type="aff" rid="minf202000028-aff-0001">
<sup>1</sup>
</xref><xref ref-type="author-notes" rid="minf202000028-note-1001">
<sup>&#x02020;</sup>
</xref></contrib><contrib id="minf202000028-cr-0003" contrib-type="author"><name><surname>Hsing</surname><given-names>Michael</given-names></name><xref ref-type="aff" rid="minf202000028-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="minf202000028-cr-0004" contrib-type="author"><name><surname>Ban</surname><given-names>Fuqiang</given-names></name><xref ref-type="aff" rid="minf202000028-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="minf202000028-cr-0005" contrib-type="author" corresp="yes"><name><surname>Cherkasov</surname><given-names>Artem</given-names></name><xref ref-type="aff" rid="minf202000028-aff-0001">
<sup>1</sup>
</xref><address><email>acherkasov@prostatecentre.com</email></address></contrib></contrib-group><aff id="minf202000028-aff-0001">
<label><sup>1</sup></label>
<named-content content-type="organisation-division">Vancouver Prostate Centre</named-content>
<institution>University of British Columbia</institution>
<named-content content-type="street">2660 Oak Street</named-content>
<city>Vancouver, BC</city>
<postal-code>V6H 3Z6</postal-code>
<country country="CA">Canada</country>
</aff><author-notes><fn id="minf202000028-note-1001"><label>&#x02020;</label><p>Equal contribution</p></fn></author-notes><pub-date pub-type="epub"><day>23</day><month>3</month><year>2020</year></pub-date><elocation-id>10.1002/minf.202000028</elocation-id><history><date date-type="received"><day>22</day><month>2</month><year>2020</year></date><date date-type="accepted"><day>11</day><month>3</month><year>2020</year></date></history><permissions><!--<copyright-statement content-type="issue-copyright"> &#x000a9; 2020 Wiley&#x02010;VCH Verlag GmbH & Co. KGaA, Weinheim <copyright-statement>--><copyright-statement content-type="article-copyright">&#x000a9; 2020 Wiley&#x02010;VCH Verlag GmbH &#x00026; Co. KGaA, Weinheim</copyright-statement><license><license-p>This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="file:MINF-9999-na.pdf"/><abstract><title>Abstract</title><p>The recently emerged 2019 Novel Coronavirus (SARS&#x02010;CoV&#x02010;2) and associated COVID&#x02010;19 disease cause serious or even fatal respiratory tract infection and yet no approved therapeutics or effective treatment is currently available to effectively combat the outbreak. This urgent situation is pressing the world to respond with the development of novel vaccine or a small molecule therapeutics for SARS&#x02010;CoV&#x02010;2. Along these efforts, the structure of SARS&#x02010;CoV&#x02010;2 main protease (Mpro) has been rapidly resolved and made publicly available to facilitate global efforts to develop novel drug candidates. Recently, our group has developed a novel deep learning platform &#x02013; Deep Docking (DD) which provides fast prediction of docking scores of Glide (or any other docking program) and, hence, enables structure&#x02010;based virtual screening of billions of purchasable molecules in a short time. In the current study we applied DD to all 1.3&#x02005;billion compounds from ZINC15 library to identify top 1,000 potential ligands for SARS&#x02010;CoV&#x02010;2 Mpro protein. The compounds are made publicly available for further characterization and development by scientific community.</p></abstract><abstract abstract-type="graphical"><p>
<boxed-text position="anchor" content-type="graphic" orientation="portrait"><graphic xlink:href="MINF-9999-na-g017.jpg" position="anchor" id="nlm-graphic-1" orientation="portrait"/></boxed-text>
</p></abstract><kwd-group kwd-group-type="author-generated"><kwd id="minf202000028-kwd-0001">SARS-CoV-2</kwd><kwd id="minf202000028-kwd-0002">COVID-19</kwd><kwd id="minf202000028-kwd-0003">deep learning</kwd><kwd id="minf202000028-kwd-0004">virtual screening</kwd><kwd id="minf202000028-kwd-0005">protease inhibitors</kwd></kwd-group><funding-group><award-group id="funding-0001"><funding-source>CIHR Canadian 2019 Novel Coronavirus (2019-nCoV)</funding-source><award-id>DC0190GP</award-id></award-group></funding-group><counts><fig-count count="16"/><table-count count="1"/><ref-count count="58"/><page-count count="1"/><word-count count="0"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>edited-state</meta-name><meta-value>corrected-proof</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:5.8.0 mode:remove_FC converted:16.04.2020</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="minf202000028-sec-0001"><label>1</label><title>Introduction</title><p>Coronaviruses (CoVs) are enveloped viruses containing a single positive&#x02010;stranded RNA, and causing a wide array of respiratory, gastrointestinal, and neurological diseases in human hosts.<xref rid="minf202000028-bib-0001" ref-type="ref">1</xref>, <xref rid="minf202000028-bib-0002" ref-type="ref">2</xref> It has been established that strains of CoVs were at the source of the 2002 severe acute respiratory syndrome (SARS) and 2012 middle east respiratory syndrome (MERS) epidemics.<xref rid="minf202000028-bib-0003" ref-type="ref">3</xref> In late December 2019, a novel CoV of SARS&#x02010;CoV&#x02010;2 was identified to be the cause of atypical pneumonia outbreak in Wuhan, China, named COVID&#x02010;19.<xref rid="minf202000028-bib-0004" ref-type="ref">4</xref> The rapidly increasing number of infected patients worldwide prompted the World Health Organization to declare a state of global health emergency to coordinate scientific and medical efforts to rapidly develop a cure for patients.<xref rid="minf202000028-bib-0005" ref-type="ref">5</xref> While drug repurposing may be a short&#x02010;term and non&#x02010;specific solution to treat COVID&#x02010;19 patients,<xref rid="minf202000028-bib-0006" ref-type="ref">6</xref> development of more targeted inhibitors is highly desirable.</p><p>Previous research efforts to develop anti&#x02010;viral agents against members of Coronaviridae family demonstrated that the Angiotensin&#x02010;converting enzyme II (ACE2) entry receptor, the RNA&#x02010;dependent RNA polymerase (RdRp) and the main protease (Mpro) proteins may represent suitable drug targets.<xref rid="minf202000028-bib-0007" ref-type="ref">7</xref> Although initially promising, inhibitors targeting ACE2 (hence aiming to block critical coronavirus&#x02010;host interactions) did not advance clinically due to significant side effects.<xref rid="minf202000028-bib-0008" ref-type="ref">8</xref> Likewise, RdRp inhibitors appeared to be not very specific and demonstrated overall lower potency, that also translated into common side effects in patients.<xref rid="minf202000028-bib-0001" ref-type="ref">1</xref>, <xref rid="minf202000028-bib-0009" ref-type="ref">9</xref> Nevertheless, rapid drug repurposing efforts have identified Remdesivir, a RdRp inhibitor, as a promising antiviral drug against COVID&#x02010;19.<xref rid="minf202000028-bib-0010" ref-type="ref">10</xref>, <xref rid="minf202000028-bib-0011" ref-type="ref">11</xref> Clinical trials are currently ongoing to determine the full efficacy spectrum of the compound in patients (clinicaltrials.gov, NCT04280705<xref rid="minf202000028-bib-0012" ref-type="ref">12</xref>). Concurrently, CoV infected patients administered with protease inhibitors, lopinavir/ritonavir, have shown improved outcome,<xref rid="minf202000028-bib-0001" ref-type="ref">1</xref>, <xref rid="minf202000028-bib-0013" ref-type="ref">13</xref> demonstrating the potential of the main protease (Mpro) as the most promising drug target in CoVs<xref rid="minf202000028-bib-0014" ref-type="ref">14</xref>, <xref rid="minf202000028-bib-0015" ref-type="ref">15</xref> Hence, a recently published X&#x02010;ray crystal structure of the SARS&#x02010;CoV&#x02010;2 Mpro provides an excellent ground for structure&#x02010;based drug discovery efforts.<xref rid="minf202000028-bib-0016" ref-type="ref">16</xref>
</p><p>Earlier efforts to target SARS&#x02010;CoV resulted in identification of several covalent Mpro inhibitors targeting the catalytic dyad of the protein defined by His41 and Cys145<xref rid="minf202000028-bib-0017" ref-type="ref">17</xref> residues. However, covalent inhibitors are often marked by adverse drug responses, off&#x02010;target side effects, toxicity and lower potency.<xref rid="minf202000028-bib-0018" ref-type="ref">18</xref>, <xref rid="minf202000028-bib-0019" ref-type="ref">19</xref>, <xref rid="minf202000028-bib-0020" ref-type="ref">20</xref>, <xref rid="minf202000028-bib-0021" ref-type="ref">21</xref>, <xref rid="minf202000028-bib-0022" ref-type="ref">22</xref> Therefore, noncovalent protease inhibitors may have advantages for the treatment of this kind of infections. Still, the majority of approved drugs administered as anti&#x02010;SARS were designed for other viral strains (Table&#x02005;S1 in supplementary material). Notably, no CoV&#x02010;protease specific inhibitor has yet successfully completed a clinical development program to date.<xref rid="minf202000028-bib-0019" ref-type="ref">19</xref>, <xref rid="minf202000028-bib-0023" ref-type="ref">23</xref>
</p><p>The impact of current COVID&#x02010;19 outbreak and the likelihood of future CoV epidemics strongly advocate for rapid development of new treatments and fast intervention protocols. Few research groups have already suggested potential repurposing strategies for clinically approved drugs<xref rid="minf202000028-bib-0024" ref-type="ref">24</xref>, <xref rid="minf202000028-bib-0025" ref-type="ref">25</xref>, <xref rid="minf202000028-bib-0026" ref-type="ref">26</xref> or proposed de novo agents<xref rid="minf202000028-bib-0027" ref-type="ref">27</xref> as therapeutic solutions for SARS&#x02010;CoV&#x02010;2. However, previously reported docking (virtual screening) campaigns with Mpro targets were able to process only few millions or even thousands compounds.<xref rid="minf202000028-bib-0006" ref-type="ref">6</xref>, <xref rid="minf202000028-bib-0028" ref-type="ref">28</xref>, <xref rid="minf202000028-bib-0029" ref-type="ref">29</xref>, <xref rid="minf202000028-bib-0030" ref-type="ref">30</xref> The main reason for that is that conventional docking is too computationally expensive and slow, while the libraries of available chemicals are growing exponentially.<xref rid="minf202000028-bib-0031" ref-type="ref">31</xref> To address this general challenge, we have recently developed a novel deep learning&#x02010;based approach for accelerated screening of large chemical libraries, consisting of billions of entities. This Deep Docking (DD) platform utilizes quantitative structure&#x02010;activity relationship (QSAR) models trained on docking scores of database subsets to approximate in an iterative manner the docking outcome of the remaining entries. Importantly, DD does not provide any novel scoring function for docking, thus its accuracy relies completely on the docking program that is used. The development of deep learning scoring functions has been already attempted, but results have shown various degrees of success which could be due to a lack of appropriate datasets.<xref rid="minf202000028-bib-0032" ref-type="ref">32</xref>, <xref rid="minf202000028-bib-0033" ref-type="ref">33</xref> Likely, as the very nature of docking is approximate, the improvements are likely to come from better approximation of physical&#x02010;chemical processes, including solvation, enthalpic and entropic factors, rather than from a better training base and procedures.<xref rid="minf202000028-bib-0034" ref-type="ref">34</xref>, <xref rid="minf202000028-bib-0035" ref-type="ref">35</xref> Thus, our method represents not just feasible, but also practical options for utilizing deep learning in virtual screening. Herein we have used DD for large&#x02010;scale virtual screening against the SARS&#x02010;CoV&#x02010;2 Mpro active site.</p></sec><sec id="minf202000028-sec-0002"><label>2</label><title>Materials and Methods</title><p>To assess the performance of fast Glide SP protocol<xref rid="minf202000028-bib-0036" ref-type="ref">36</xref> to virtually screen against the Mpro target, we collected 81 known SARS Mpro small molecule inhibitors that are reported by Pillaiyar et&#x02005;al.,<xref rid="minf202000028-bib-0037" ref-type="ref">37</xref> and Turlington et&#x02005;al..<xref rid="minf202000028-bib-0038" ref-type="ref">38</xref> Then, we generated 50 molecular decoys for each active molecules using the methodology implemented in the Database of Useful Decoys: Enhanced (DUD&#x02212;E).<xref rid="minf202000028-bib-0039" ref-type="ref">39</xref> All compounds were prepared for docking with the OpenEye package. Most probable tautomer and ionization states at pH&#x02005;7.4 were calculated with OpenEye QUACPAC package<xref rid="minf202000028-bib-0040" ref-type="ref">40</xref> and starting 3D conformations were generated using Omega <italic>pose</italic> routine.<xref rid="minf202000028-bib-0041" ref-type="ref">41</xref> The structure of SARS Mpro bound to a noncovalent inhibitor (PDB 4MDS, 1.6&#x02005;&#x000c5; resolution) was obtained from the Protein Data Bank (PDB),<xref rid="minf202000028-bib-0042" ref-type="ref">42</xref> and prepared using Protein Preparation Wizard.<xref rid="minf202000028-bib-0043" ref-type="ref">43</xref> Docking was performed using Glide SP module.<xref rid="minf202000028-bib-0036" ref-type="ref">36</xref> Receiver operating curve areas under the curve (ROC AUC) were then calculated.</p><p>We used DD to virtually screen all ZINC15 (1.36&#x02005;billion compounds)<xref rid="minf202000028-bib-0044" ref-type="ref">44</xref> against the SARS&#x02010;CoV&#x02010;2 Mpro. The model was initialized by randomly sampling 3&#x02005;million molecules and dividing them evenly into training, validation and test set. The structure PDB 6LU7 (resolution 2.16&#x02005;&#x000c5;)<xref rid="minf202000028-bib-0045" ref-type="ref">45</xref> of the SARS&#x02010;CoV&#x02010;2 Mpro bound to the N3 covalent inhibitor was obtained from the PDB, and prepared as before. Molecule preparation and docking were performed similarly as before, and computed scores were used for DNN initialization. We then ran 4 iterations, adding each time 1&#x02005;million of docked molecules sampled from previous predictions to the training set and setting the recall of top scoring compounds to 0.75. At the end of the 4<sup>th</sup> iteration, the top 3&#x02005;million molecules predicted to have favorable scores were then docked to the protease site. The set of protease inhibitors (7,800 compounds) from the BindingDB repository was also docked to the same site.<xref rid="minf202000028-bib-0046" ref-type="ref">46</xref> Our computational setup consisted of 13 Intel(R) Xeon(R) Gold 6130 CPUs @ 2.10GHz (a total of 390 cores) for docking, and 40 Nvidia Tesla V100 GPUs with 32GB memory for deep learning.</p></sec><sec id="minf202000028-sec-0003"><label>3</label><title>Results and Discussion</title><p>Although drug repurposing and high&#x02010;throughput screening have identified potential hit compounds with strong antiviral activity against COVID&#x02010;19,<xref rid="minf202000028-bib-0047" ref-type="ref">47</xref> no noncovalent inhibitors for SARS&#x02010;CoV&#x02010;2 Mpro have been reported to date. Glide protocols were recently deployed to identify potential hit compounds as protease inhibitors, notably against FP&#x02010;2 and FP&#x02010;3 (<italic>P. falciparum</italic> cysteine protease),<xref rid="minf202000028-bib-0048" ref-type="ref">48</xref> nsP2 (Chikunguya virus protease),<xref rid="minf202000028-bib-0049" ref-type="ref">49</xref> and more recently against SARS&#x02010;CoV&#x02010;2 MPro.<xref rid="minf202000028-bib-0047" ref-type="ref">47</xref> Therefore, Glide was shown to be adequate and effective in docking ligands with high fidelity compared to other available academic and commercial docking software.<xref rid="minf202000028-bib-0050" ref-type="ref">50</xref>, <xref rid="minf202000028-bib-0051" ref-type="ref">51</xref> Nonetheless, we performed our own benchmarking study to evaluate the viability of using Glide SP to screen the SARS&#x02010;CoV&#x02010;2 Mpro.</p><p>We first evaluated the feasibility of virtual screening using a closely related protein, the SARS Mpro (96&#x02009;% of sequence identity,) for which different series of noncovalent inhibitors with low micromolar to nanomolar acitivity have been discovered.<xref rid="minf202000028-bib-0037" ref-type="ref">37</xref>
</p><p>Our benchmarking study revealed good ability of Glide SP to dock known inhibitors. First, the co&#x02010;crystallized ligand (SID 24808289 from Turlington et&#x02005;al.<xref rid="minf202000028-bib-0038" ref-type="ref">38</xref>) was accurately redocked to its binding site (root mean square deviation (r.m.s.d.) of 0.86&#x02005;&#x000c5; between Glide and x&#x02010;ray pose, Figure&#x02005;<xref rid="minf202000028-fig-0001" ref-type="fig">1</xref>a). Second, ROC AUC value for Glide SP used to dock 81 Mpro inhibitors and &#x0223c;4,000 decoys was 0.72, similarly to the more computationally expensive Glide XP protocol (Figure&#x02005;<xref rid="minf202000028-fig-0001" ref-type="fig">1</xref>b), and 0.74 when active molecules were diluted in 1&#x02005;million random compounds extracted from ZINC15 (Figure&#x02005;S1 in supplementary material). Thus, in light of recent studies advocating for extending virtual screening to large chemical libraries when docking works well at smaller scales,<xref rid="minf202000028-bib-0031" ref-type="ref">31</xref> we decided to use Glide SP as DD docking program to screen ZINC15 against SARS&#x02010;CoV&#x02010;2 Mpro.
</p><fig fig-type="Figure" xml:lang="en" id="minf202000028-fig-0001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Evaluation of Glide SP docking protocol on SARS Mpro inhibitors. a) Redocking of ligand 7 to the SARS Mpro active site (PDB 4MDS) resulted in 0.86&#x02005;&#x000c5; of r.m.s.d (root mean square deviation) between computational (pink) and x&#x02010;ray (cyan) poses. b) ROC curves and AUC obtained by docking 81 inhibitors and &#x0223c;4,000 decoys to the Mpro active site with Glide SP and XP protocols.</p></caption><graphic id="nlm-graphic-3" xlink:href="MINF-9999-na-g001"/></fig><p>DD relies on a deep neural network trained with docking scores of small random samples of molecules extracted from a large database to predict the scores of remaining molecules and, therefore, discard low scoring molecules without investing time and resources to dock them. The combination of an iterative process to improve model training and the use of simple 2D QSAR descriptors such as Morgan fingerprints makes DD particularly suited for fast virtual screening of emerging giga&#x02010;sized chemical libraries using standard computational resources. We have recently showed the wide range of applicability of DD by using the method to dock all ZINC15 compounds to 12 targets representing major protein families of therapeutic interest.<xref rid="minf202000028-bib-0052" ref-type="ref">52</xref>
</p><p>The use of DD platform enabled us to dock 1.3&#x02005;billion compounds from ZINC15 database<xref rid="minf202000028-bib-0044" ref-type="ref">44</xref> into SARS&#x02010;CoV&#x02010;2 Mpro active site using standard Glide SP protocols in a week. In our benchmark study on SARS Mpro, AUC ROC for Glide SP improved from 0.72 to 0.78, when a ligand efficiency (LE) cutoff of &#x02212;0.20&#x02005;kcal/mol was introduced prior to ranking molecules by their docking scores (Figure&#x02005;S2 in supplementary material). Thus, the top 1,000 hits selected from the DD run were picked following the same strategy.</p><p>The SARS Mpro cleaves the replicase polyproteins, pp1a and pp1b, at 11 specific positions, using core sequences in the polyprotein substrate to determine cleavage sites.<xref rid="minf202000028-bib-0053" ref-type="ref">53</xref> The positions of the residues on the polyproteins are named depending on their relative position to the cleavage site. Position P1 corresponds to the residue just before the cleavage site, followed by P2, P3, P4, P5, and up until the N&#x02010;terminal of the cleavage site. Position P1&#x02032; corresponds to the residue immediately following the cleavage site, followed by P2&#x02032;, P3&#x02032;, P4&#x02032;, P5&#x02032; and up until the C&#x02010;terminal of the cleavage site.<xref rid="minf202000028-bib-0054" ref-type="ref">54</xref> The protease recognizes specific residues at each position of the polyproteins to determine a cleavage site and initiate the replication&#x02010;transcription complex necessary for viral replication.<xref rid="minf202000028-bib-0055" ref-type="ref">55</xref>
</p><p>Based on the consensus recognition sequence of the polyproteins, a substrate&#x02010;analogue inhibitor, CMK, was designed to mimic positions P1 to P6 of the substrate in the SARS Mpro substrate&#x02010;binding sites. The compound is characterised by its chloromethyl ketone warhead and its core sequence of Val(P6)&#x02010;Asn(P5)&#x02010;Ser(P4)&#x02010;Thr(P3)&#x02010;Leu(P2)&#x02010;Gln(P1) to occupy the same volume as the residues of the recognition sequence.<xref rid="minf202000028-bib-0056" ref-type="ref">56</xref> An X&#x02010;ray crystallography structure of the SARS Mpro with the CMK inhibitor revealed the mode of inhibitor binding to the substrate&#x02010;binding sites of the main protease, providing a crucial structural basis for rational drug design and guiding drug discovery efforts against the SARS Mpro (PDB 1UK4<xref rid="minf202000028-bib-0057" ref-type="ref">57</xref>). Therefore, the pocket of the Mpro can be partitioned into different sections, depending on the volume occupied by polyprotein residues at each positions.</p><p>Using insight gained from the crystal structure, Turlington et&#x02005;al. first developed a moderate noncovalent inhibitor, SID 24808289, with an IC<sub>50</sub> of 6.2&#x02005;&#x003bc;M,<xref rid="minf202000028-bib-0038" ref-type="ref">38</xref> and demonstrated that additional positions could be explored for efficient inhibition of SARS Mpro. The binding pose of the compound is shown in Figure&#x02005;<xref rid="minf202000028-fig-0002" ref-type="fig">2</xref>, and the compound occupies the same volume as positions P1 to P4, and P1&#x02032;. The compound still maintained key interactions with catalytic dyad of Gln189 and Met49 through hydrophobic contacts (P2), and through hydrogen bonds to Cys145, His163, and Glu166 (P1).
</p><fig fig-type="Figure" xml:lang="en" id="minf202000028-fig-0002" orientation="portrait" position="float"><label>Figure 2</label><caption><p>P1, P2, P3 and P1&#x02032; groups in the substrate&#x02010;binding subsites of SARS MPro (PDB 4MDS). The compound, SID 24808289, is represented as orange sticks. The surface of the protease binding site is partitioned into different sections depending on the pocket occupancy of the compound.</p></caption><graphic id="nlm-graphic-5" xlink:href="MINF-9999-na-g002"/></fig><p>The number 1 series of compounds identified from our virtual screening is presented in Table&#x02005;<xref rid="minf202000028-tbl-0001" ref-type="table">1</xref>. They are predicted to have consistent binding pose, similar to the noncovalent compound SID 24808289, as shown in Figure&#x02005;<xref rid="minf202000028-fig-0003" ref-type="fig">3</xref>a. The predicted interaction between ZINC000541677852 and SARS&#x02010;CoV&#x02010;2 Mpro is shown in Figure&#x02005;<xref rid="minf202000028-fig-0003" ref-type="fig">3</xref>b. This series of compounds occupied the same volume as the P1, P2 and P3 groups with the common favored hydrophobic interactions of the phenyl ring (P2), and two hydrogen bonds to Cys145 and Leu141 respectively (P1).
</p><table-wrap id="minf202000028-tbl-0001" xml:lang="en" orientation="portrait" position="float"><label>Table 1</label><caption><p>Top hit series identified from our DD.
<inline-graphic xlink:href="MINF-9999-na-g005.jpg" xlink:title="image"/>
</p></caption><table frame="hsides" rules="groups"><col span="1"/><col span="1"/><col span="1"/><col span="1"/><thead valign="top"><tr style="border-bottom:solid 1px #000000"><th valign="top" rowspan="1" colspan="1">
<p>Compound</p>
</th><th valign="top" rowspan="1" colspan="1">
<p>R1</p>
</th><th valign="top" rowspan="1" colspan="1">
<p>R2</p>
</th><th valign="top" rowspan="1" colspan="1">
<p>Glide score (kcal/mol)</p>
</th></tr></thead><tbody><tr><td valign="middle" rowspan="1" colspan="1">
<p>ZINC000541677852</p>
</td><td valign="middle" rowspan="1" colspan="1">
<p>CF<sub>3</sub>
<sup>&#x02212;&#x02212;&#x02212;&#x02212;</sup>
</p>
</td><td valign="middle" rowspan="1" colspan="1">
<p>
<inline-graphic xlink:href="MINF-9999-na-g006.jpg" xlink:title="image"/>
</p>
</td><td valign="middle" rowspan="1" colspan="1">
<p>&#x02010;11.32</p>
</td></tr><tr><td valign="middle" rowspan="1" colspan="1">
<p>ZINC000636416501</p>
</td><td valign="middle" rowspan="1" colspan="1">
<p>Cl<sup>&#x02212;&#x02212;&#x02212;&#x02212;</sup>
</p>
</td><td valign="middle" rowspan="1" colspan="1">
<p>
<inline-graphic xlink:href="MINF-9999-na-g007.jpg" xlink:title="image"/>
</p>
</td><td valign="middle" rowspan="1" colspan="1">
<p>&#x02010;10.85</p>
</td></tr><tr><td valign="middle" rowspan="1" colspan="1">
<p>ZINC000543523838</p>
</td><td valign="middle" rowspan="1" colspan="1">
<p>Br<sup>&#x02212;&#x02212;&#x02212;&#x02212;</sup>
</p>
</td><td valign="middle" rowspan="1" colspan="1">
<p>
<inline-graphic xlink:href="MINF-9999-na-g008.jpg" xlink:title="image"/>
</p>
</td><td valign="middle" rowspan="1" colspan="1">
<p>&#x02010;10.75</p>
</td></tr><tr><td valign="middle" rowspan="1" colspan="1">
<p>ZINC000544491494</p>
</td><td valign="middle" rowspan="1" colspan="1">
<p>Br<sup>&#x02212;&#x02212;&#x02212;&#x02212;</sup>
</p>
</td><td valign="middle" rowspan="1" colspan="1">
<p>
<inline-graphic xlink:href="MINF-9999-na-g009.jpg" xlink:title="image"/>
</p>
</td><td valign="middle" rowspan="1" colspan="1">
<p>&#x02010;10.65</p>
</td></tr><tr><td valign="middle" rowspan="1" colspan="1">
<p>ZINC000544491491</p>
</td><td valign="middle" rowspan="1" colspan="1">
<p>Br<sup>&#x02212;&#x02212;&#x02212;&#x02212;</sup>
</p>
</td><td valign="middle" rowspan="1" colspan="1">
<p>
<inline-graphic xlink:href="MINF-9999-na-g010.jpg" xlink:title="image"/>
</p>
</td><td valign="middle" rowspan="1" colspan="1">
<p>&#x02010;10.50</p>
</td></tr><tr><td valign="middle" rowspan="1" colspan="1">
<p>ZINC000541676760</p>
</td><td valign="middle" rowspan="1" colspan="1">
<p>CF<sub>3</sub>
<sup>&#x02212;&#x02212;&#x02212;&#x02212;</sup>
</p>
</td><td valign="middle" rowspan="1" colspan="1">
<p>
<inline-graphic xlink:href="MINF-9999-na-g011.jpg" xlink:title="image"/>
</p>
</td><td valign="middle" rowspan="1" colspan="1">
<p>&#x02010;10.48</p>
</td></tr><tr><td valign="middle" rowspan="1" colspan="1">
<p>ZINC000543523837</p>
</td><td valign="middle" rowspan="1" colspan="1">
<p>Br<sup>&#x02212;&#x02212;&#x02212;&#x02212;</sup>
</p>
</td><td valign="middle" rowspan="1" colspan="1">
<p>
<inline-graphic xlink:href="MINF-9999-na-g012.jpg" xlink:title="image"/>
</p>
</td><td valign="middle" rowspan="1" colspan="1">
<p>&#x02010;10.43</p>
</td></tr><tr><td valign="middle" rowspan="1" colspan="1">
<p>ZINC000152979101</p>
</td><td valign="middle" rowspan="1" colspan="1">
<p>Br<sup>&#x02212;&#x02212;&#x02212;&#x02212;</sup>
</p>
</td><td valign="middle" rowspan="1" colspan="1">
<p>
<inline-graphic xlink:href="MINF-9999-na-g013.jpg" xlink:title="image"/>
</p>
</td><td valign="middle" rowspan="1" colspan="1">
<p>&#x02010;10.33</p>
</td></tr><tr><td valign="middle" rowspan="1" colspan="1">
<p>ZINC000152975931</p>
</td><td valign="middle" rowspan="1" colspan="1">
<p>CF<sub>3</sub>
<sup>&#x02212;&#x02212;&#x02212;&#x02212;</sup>
</p>
</td><td valign="middle" rowspan="1" colspan="1">
<p>
<inline-graphic xlink:href="MINF-9999-na-g014.jpg" xlink:title="image"/>
</p>
</td><td valign="middle" rowspan="1" colspan="1">
<p>&#x02010;10.03</p>
</td></tr><tr><td valign="middle" rowspan="1" colspan="1">
<p>ZINC001627499877</p>
</td><td valign="middle" rowspan="1" colspan="1">
<p>Br<sup>&#x02212;&#x02212;&#x02212;&#x02212;</sup>
</p>
</td><td valign="middle" rowspan="1" colspan="1">
<p>
<inline-graphic xlink:href="MINF-9999-na-g015.jpg" xlink:title="image"/>
</p>
</td><td valign="middle" rowspan="1" colspan="1">
<p>&#x02010;9.32</p>
</td></tr><tr><td valign="middle" rowspan="1" colspan="1">
<p>ZINC001362111980</p>
</td><td valign="middle" rowspan="1" colspan="1">
<p>Cl<sup>&#x02212;&#x02212;&#x02212;&#x02212;</sup>
</p>
</td><td valign="middle" rowspan="1" colspan="1">
<p>
<inline-graphic xlink:href="MINF-9999-na-g016.jpg" xlink:title="image"/>
</p>
</td><td valign="middle" rowspan="1" colspan="1">
<p>&#x02010;9.13</p>
</td></tr></tbody></table><permissions><copyright-holder>Wiley&#x02010;VCH Verlag GmbH &#x00026; Co. KGaA</copyright-holder><license><license-p>This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.</license-p></license></permissions></table-wrap><fig fig-type="Figure" xml:lang="en" id="minf202000028-fig-0003" orientation="portrait" position="float"><label>Figure 3</label><caption><p>a) Predicted binding pose of our top hit compound (shown in magenta sticks) in the SARS&#x02010;CoV&#x02010;2 pocket with the annotated pocket occupancy b) Representation of the interactions of ZINC000541677852 in the SARS&#x02010;CoV&#x02010;2 pocket. Blue dotted lines represent hydrogen bonds with protein backbone atoms, and green dotted lines represent hydrogen bonds with sidechain atoms.</p></caption><graphic id="nlm-graphic-7" xlink:href="MINF-9999-na-g003"/></fig><p>We have also analyzed the origin of top 1,000 ZINC hits (selected by LE), and observed that 99&#x02009;% of them are not present in the ZINC15 in&#x02010;stock library (&#x0223c;11&#x02005;millions of molecules), commonly used in routine docking campaigns, demonstrating that the DD methodology can access complete and diverse chemical space beyond classical docking. The Glide SP scores of the top 1,000 candidates we selected were significantly better than top 1,000 molecules from a 1&#x02005;million random sample of ZINC15 entries, and even better than top candidates from BindingDB protease inhibitor library, which were docked to the same site (Figure&#x02005;<xref rid="minf202000028-fig-0004" ref-type="fig">4</xref>).
</p><fig fig-type="Figure" xml:lang="en" id="minf202000028-fig-0004" orientation="portrait" position="float"><label>Figure 4</label><caption><p>Score probability of top 1,000 ranked compounds extracted from docking of a set of protease inhibitors (7,800 compounds), a random sample of ZINC15 (1&#x02005;million molecules) and top 1&#x02005;million molecules from DD.</p></caption><graphic id="nlm-graphic-9" xlink:href="MINF-9999-na-g004"/></fig><p>We also evaluated the chemical diversity of the newly identified set of inhibitors compared to the protease library. Calculation of Murcko frameworks<xref rid="minf202000028-bib-0058" ref-type="ref">58</xref> for hits from such library and DD hits revealed a similar number of frameworks present in the two sets (603 and 587 scaffolds, respectively). Encouragingly, we observed just two common frameworks, clearly indicating that screening 1.36&#x02005;billion enables identification of new chemical classes that can potentially inhibit SARS&#x02010;COV&#x02010;2 Mpro. Thus, DD allowed us to rapidly narrow down ZINC15 to a smaller dataset enriched with high scoring compounds, which consists of novel molecules with highly favourable docking scores as well as significantly different structures than known protease inhibitors.</p><p>Our DD screening identified 585 new scaffolds for SARS&#x02010;CoV&#x02010;2 that are not shared with known protease inhibitors, although they can establish all the critical interactions with the protease active site, thus providing a completely new set of chemicals for testing and optimization. Collectively, our results strongly support the use of docking the largest available compound library for identifying novel potent scaffolds or chemicals, as concluded by Lyu et&#x02005;al..<xref rid="minf202000028-bib-0031" ref-type="ref">31</xref>
</p></sec><sec id="minf202000028-sec-0004"><label>4</label><title>Conclusions</title><p>The use of DD methodology in conjunction with Glide allowed rapid estimation of docking scores for 1.3&#x02005;billion chemical structures into an active site of novel SARS&#x02010;CoV&#x02010;2 Mpro. The candidate inhibitors in the top&#x02010;1,000 hit list are chemically diverse, exhibit superior docking scores compared to known protease inhibitors, and can be readily sourced from established vendors. The structures of the identified compounds are made publicly available and should facilitate international efforts in rapid development of suitable drug candidates against COVID&#x02010;19.</p></sec><sec id="minf202000028-sec-0005"><label>5</label><title>Data Dissemination</title><p>List of the top 1,000 identified compounds, as well as docking results in SDF format are publicly available at <ext-link ext-link-type="uri" xlink:href="http://drive.google.com/drive/folders/1xgA8ScPRqIunxEAXFrUEkavS7y3tLIMN?usp=sharing">http://drive.google.com/drive/folders/1xgA8ScPRqIunxEAXFrUEkavS7y3tLIMN?usp=sharing</ext-link>.</p></sec><sec sec-type="COI-statement" id="minf202000028-sec-0006"><title>Conflict of Interest</title><p>None declared.</p></sec><sec sec-type="supplementary-material"><title>Supporting information</title><supplementary-material content-type="local-data"><p>As a service to our authors and readers, this journal provides supporting information supplied by the authors. Such materials are peer reviewed and may be re&#x02010;organized for online delivery, but are not copy&#x02010;edited or typeset. Technical support issues arising from supporting information (other than missing files) should be addressed to the authors.</p></supplementary-material><supplementary-material content-type="local-data"><caption><p>Supplementary</p></caption><media xlink:href="MINF-9999-na-s001.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data"><caption><p>Supplementary</p></caption><media xlink:href="MINF-9999-na-s002.xlsx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack id="minf202000028-sec-0007"><title>Acknowledgements</title><p>This work was funded by the CIHR Canadian 2019 Novel Coronavirus (2019&#x02010;nCoV) Rapid Research grant # DC0190GP.</p></ack><ref-list><title>References</title><ref id="minf202000028-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="minf202000028-cit-0001">
<string-name>
<given-names>A.</given-names>
<surname>Zumla</surname>
</string-name>, <string-name>
<given-names>J. F. W.</given-names>
<surname>Chan</surname>
</string-name>, <string-name>
<given-names>E. I.</given-names>
<surname>Azhar</surname>
</string-name>, <string-name>
<given-names>D. S. C.</given-names>
<surname>Hui</surname>
</string-name>, <string-name>
<given-names>K.-Y.</given-names>
<surname>Yuen</surname>
</string-name>, <source xml:lang="en">Nat. Rev. Drug Discovery</source>
<year>2016</year>, <volume>15</volume>, <fpage>327</fpage>&#x02013;<lpage>347</lpage>.<pub-id pub-id-type="pmid">26868298</pub-id></mixed-citation></ref><ref id="minf202000028-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="minf202000028-cit-0002">
<string-name>
<given-names>E.</given-names>
<surname>de Wit</surname>
</string-name>, <string-name>
<given-names>N.</given-names>
<surname>van Doremalen</surname>
</string-name>, <string-name>
<given-names>D.</given-names>
<surname>Falzarano</surname>
</string-name>, <string-name>
<given-names>V. J.</given-names>
<surname>Munster</surname>
</string-name>, <source xml:lang="en">Nat. Rev. Microbiol.</source>
<year>2016</year>, <volume>14</volume>, <fpage>523</fpage>&#x02013;<lpage>534</lpage>.<pub-id pub-id-type="pmid">27344959</pub-id></mixed-citation></ref><ref id="minf202000028-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="minf202000028-cit-0003">
<string-name>
<given-names>Z.</given-names>
<surname>Song</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Xu</surname>
</string-name>, <string-name>
<given-names>L.</given-names>
<surname>Bao</surname>
</string-name>, <string-name>
<given-names>L.</given-names>
<surname>Zhang</surname>
</string-name>, <string-name>
<given-names>P.</given-names>
<surname>Yu</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Qu</surname>
</string-name>, <string-name>
<given-names>H.</given-names>
<surname>Zhu</surname>
</string-name>, <string-name>
<given-names>W.</given-names>
<surname>Zhao</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Han</surname>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Qin</surname>
</string-name>, <source xml:lang="en">Viruses</source>
<year>2019</year>, <volume>11</volume>, DOI <fpage>10</fpage>.3390/v11010059.</mixed-citation></ref><ref id="minf202000028-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="minf202000028-cit-0004">
<string-name>
<given-names>D. S.</given-names>
<surname>Hui</surname>
</string-name>, <string-name>
<given-names>E. I.</given-names>
<surname>Azhar</surname>
</string-name>, <string-name>
<given-names>T. A.</given-names>
<surname>Madani</surname>
</string-name>, <string-name>
<given-names>F.</given-names>
<surname>Ntoumi</surname>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Kock</surname>
</string-name>, <string-name>
<given-names>O.</given-names>
<surname>Dar</surname>
</string-name>, <string-name>
<given-names>G.</given-names>
<surname>Ippolito</surname>
</string-name>, <string-name>
<given-names>T. D.</given-names>
<surname>Mchugh</surname>
</string-name>, <string-name>
<given-names>Z. A.</given-names>
<surname>Memish</surname>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Drosten</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Zumla</surname>
</string-name>, <string-name>
<given-names>E.</given-names>
<surname>Petersen</surname>
</string-name>, <source xml:lang="en">Int. J. Infect. Dis.</source>
<year>2020</year>, <volume>91</volume>, <fpage>264</fpage>&#x02013;<lpage>266</lpage>.<pub-id pub-id-type="pmid">31953166</pub-id></mixed-citation></ref><ref id="minf202000028-bib-0005"><label>5</label><mixed-citation publication-type="miscellaneous" id="minf202000028-cit-0005">&#x0201c;Coronavirus latest: Chinese cases spike after changes to diagnosis method,&#x0201d; can be found under http://www.nature.com/articles/d41586-020-00154-w, <bold>2020</bold>.</mixed-citation></ref><ref id="minf202000028-bib-0006"><label>6</label><mixed-citation publication-type="miscellaneous" id="minf202000028-cit-0006">M. Wang, R. Cao, L. Zhang, X. Yang, J. Liu, M. Xu, Z. Shi, Z. Hu, W. Zhong, G. Xiao, <italic>Cell Res</italic>
<bold>2020</bold>, DOI 10.1038/s41422-020-0282-0.</mixed-citation></ref><ref id="minf202000028-bib-0007"><label>7</label><mixed-citation publication-type="miscellaneous" id="minf202000028-cit-0007">G. Li, E. De&#x02005;Clercq, <italic>Nat Rev Drug Discov</italic>
<bold>2020</bold>, d41573-020-00016-0.</mixed-citation></ref><ref id="minf202000028-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="minf202000028-cit-0008">
<string-name>
<given-names>D. P.</given-names>
<surname>Han</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Penn-Nicholson</surname>
</string-name>, <string-name>
<given-names>M. W.</given-names>
<surname>Cho</surname>
</string-name>, <source xml:lang="en">Virology</source>
<year>2006</year>, <volume>350</volume>, <fpage>15</fpage>&#x02013;<lpage>25</lpage>.<pub-id pub-id-type="pmid">16510163</pub-id></mixed-citation></ref><ref id="minf202000028-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="minf202000028-cit-0009">
<string-name>
<given-names>C. E.</given-names>
<surname>Cameron</surname>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Castro</surname>
</string-name>, <source xml:lang="en">Curr. Opin. Infect. Dis.</source>
<year>2001</year>, <volume>14</volume>, <fpage>757</fpage>&#x02013;<lpage>764</lpage>.<pub-id pub-id-type="pmid">11964896</pub-id></mixed-citation></ref><ref id="minf202000028-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="minf202000028-cit-0010">
<string-name>
<given-names>M.</given-names>
<surname>Wang</surname>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Cao</surname>
</string-name>, <string-name>
<given-names>L.</given-names>
<surname>Zhang</surname>
</string-name>, <string-name>
<given-names>X.</given-names>
<surname>Yang</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Liu</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Xu</surname>
</string-name>, <string-name>
<given-names>Z.</given-names>
<surname>Shi</surname>
</string-name>, <string-name>
<given-names>Z.</given-names>
<surname>Hu</surname>
</string-name>, <string-name>
<given-names>W.</given-names>
<surname>Zhong</surname>
</string-name>, <string-name>
<given-names>G.</given-names>
<surname>Xiao</surname>
</string-name>, <source xml:lang="en">Cell Res</source>
<year>2020</year>, <volume>30</volume>, <fpage>269</fpage>&#x02013;<lpage>271</lpage>.<pub-id pub-id-type="pmid">32020029</pub-id></mixed-citation></ref><ref id="minf202000028-bib-0011"><label>11</label><mixed-citation publication-type="miscellaneous" id="minf202000028-cit-0011">C.&#x02005;J. Gordon, E.&#x02005;P. Tchesnokov, J.&#x02005;Y. Feng, D.&#x02005;P. Porter, M. Gotte, <italic>J. Biol. Chem</italic>
<bold>2020</bold>, jbc.AC120.013056.</mixed-citation></ref><ref id="minf202000028-bib-0012"><label>12</label><mixed-citation publication-type="miscellaneous" id="minf202000028-cit-0012">&#x0201c;Adaptive COVID-19 Treatment Trial,&#x0201d; can be found under https://clinicaltrials.gov/ct2/show/NCT04280705, <bold>n.d</bold>..</mixed-citation></ref><ref id="minf202000028-bib-0013"><label>13</label><mixed-citation publication-type="journal" id="minf202000028-cit-0013">
<string-name>
<given-names>C. M.</given-names>
<surname>Chu</surname>
</string-name>, <source xml:lang="en">Thorax</source>
<year>2004</year>, <volume>59</volume>, <fpage>252</fpage>&#x02013;<lpage>256</lpage>.<pub-id pub-id-type="pmid">14985565</pub-id></mixed-citation></ref><ref id="minf202000028-bib-0014"><label>14</label><mixed-citation publication-type="journal" id="minf202000028-cit-0014">
<string-name>
<given-names>I.-L.</given-names>
<surname>Lu</surname>
</string-name>, <string-name>
<given-names>N.</given-names>
<surname>Mahindroo</surname>
</string-name>, <string-name>
<given-names>P.-H.</given-names>
<surname>Liang</surname>
</string-name>, <string-name>
<given-names>Y.-H.</given-names>
<surname>Peng</surname>
</string-name>, <string-name>
<given-names>C.-J.</given-names>
<surname>Kuo</surname>
</string-name>, <string-name>
<given-names>K.-C.</given-names>
<surname>Tsai</surname>
</string-name>, <string-name>
<given-names>H.-P.</given-names>
<surname>Hsieh</surname>
</string-name>, <string-name>
<given-names>Y.-S.</given-names>
<surname>Chao</surname>
</string-name>, <string-name>
<given-names>S.-Y.</given-names>
<surname>Wu</surname>
</string-name>, <source xml:lang="en">J. Med. Chem.</source>
<year>2006</year>, <volume>49</volume>, <fpage>5154</fpage>&#x02013;<lpage>5161</lpage>.<pub-id pub-id-type="pmid">16913704</pub-id></mixed-citation></ref><ref id="minf202000028-bib-0015"><label>15</label><mixed-citation publication-type="journal" id="minf202000028-cit-0015">
<string-name>
<given-names>J. E.</given-names>
<surname>Blanchard</surname>
</string-name>, <string-name>
<given-names>N. H.</given-names>
<surname>Elowe</surname>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Huitema</surname>
</string-name>, <string-name>
<given-names>P. D.</given-names>
<surname>Fortin</surname>
</string-name>, <string-name>
<given-names>J. D.</given-names>
<surname>Cechetto</surname>
</string-name>, <string-name>
<given-names>L. D.</given-names>
<surname>Eltis</surname>
</string-name>, <string-name>
<given-names>E. D.</given-names>
<surname>Brown</surname>
</string-name>, <source xml:lang="en">Chem. Biol.</source>
<year>2004</year>, <volume>11</volume>, <fpage>1445</fpage>&#x02013;<lpage>1453</lpage>.<pub-id pub-id-type="pmid">15489171</pub-id></mixed-citation></ref><ref id="minf202000028-bib-0016"><label>16</label><mixed-citation publication-type="miscellaneous" id="minf202000028-cit-0016">X. Liu, B. Zhang, Z. Jin, H. Yang, Z. Rao, <italic>PDB</italic>
<bold>2020</bold>, DOI 10.2210/pdb6lu7/pdb.</mixed-citation></ref><ref id="minf202000028-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="minf202000028-cit-0017">
<string-name>
<given-names>A.</given-names>
<surname>Paasche</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Zipper</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Sch&#x000e4;fer</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Ziebuhr</surname>
</string-name>, <string-name>
<given-names>T.</given-names>
<surname>Schirmeister</surname>
</string-name>, <string-name>
<given-names>B.</given-names>
<surname>Engels</surname>
</string-name>, <source xml:lang="en">Biochemistry</source>
<year>2014</year>, <volume>53</volume>, <fpage>5930</fpage>&#x02013;<lpage>5946</lpage>.<pub-id pub-id-type="pmid">25196915</pub-id></mixed-citation></ref><ref id="minf202000028-bib-0018"><label>18</label><mixed-citation publication-type="journal" id="minf202000028-cit-0018">
<string-name>
<given-names>H.</given-names>
<surname>Lee</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Mittal</surname>
</string-name>, <string-name>
<given-names>K.</given-names>
<surname>Patel</surname>
</string-name>, <string-name>
<given-names>J. L.</given-names>
<surname>Gatuz</surname>
</string-name>, <string-name>
<given-names>L.</given-names>
<surname>Truong</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Torres</surname>
</string-name>, <string-name>
<given-names>D. C.</given-names>
<surname>Mulhearn</surname>
</string-name>, <string-name>
<given-names>M. E.</given-names>
<surname>Johnson</surname>
</string-name>, <source xml:lang="en">Bioorg. Med. Chem.</source>
<year>2014</year>, <volume>22</volume>, <fpage>167</fpage>&#x02013;<lpage>177</lpage>.<pub-id pub-id-type="pmid">24332657</pub-id></mixed-citation></ref><ref id="minf202000028-bib-0019"><label>19</label><mixed-citation publication-type="book" id="minf202000028-cit-0019">
<string-name>
<given-names>A. K.</given-names>
<surname>Ghosh</surname>
</string-name>, <string-name>
<given-names>K.</given-names>
<surname>Xi</surname>
</string-name>, <string-name>
<given-names>M. E.</given-names>
<surname>Johnson</surname>
</string-name>, <string-name>
<given-names>S. C.</given-names>
<surname>Baker</surname>
</string-name>, <string-name>
<given-names>A. D.</given-names>
<surname>Mesecar</surname>
</string-name>, in <source xml:lang="en">Annual Reports in Medicinal Chemistry</source>, <publisher-name>Elsevier</publisher-name>, <year>2006</year>, pp.&#x02005;<fpage>183</fpage>&#x02013;<lpage>196</lpage>.</mixed-citation></ref><ref id="minf202000028-bib-0020"><label>20</label><mixed-citation publication-type="journal" id="minf202000028-cit-0020">
<string-name>
<given-names>A.</given-names>
<surname>Tuley</surname>
</string-name>, <string-name>
<given-names>W.</given-names>
<surname>Fast</surname>
</string-name>, <source xml:lang="en">Biochemistry</source>
<year>2018</year>, <volume>57</volume>, <fpage>3326</fpage>&#x02013;<lpage>3337</lpage>.<pub-id pub-id-type="pmid">29689165</pub-id></mixed-citation></ref><ref id="minf202000028-bib-0021"><label>21</label><mixed-citation publication-type="journal" id="minf202000028-cit-0021">
<string-name>
<given-names>B.</given-names>
<surname>Turk</surname>
</string-name>, <source xml:lang="en">Nat. Rev. Drug Discovery</source>
<year>2006</year>, <volume>5</volume>, <fpage>785</fpage>&#x02013;<lpage>799</lpage>.<pub-id pub-id-type="pmid">16955069</pub-id></mixed-citation></ref><ref id="minf202000028-bib-0022"><label>22</label><mixed-citation publication-type="journal" id="minf202000028-cit-0022">
<string-name>
<given-names>A. K.</given-names>
<surname>Ghosh</surname>
</string-name>, <string-name>
<given-names>G.</given-names>
<surname>Gong</surname>
</string-name>, <string-name>
<given-names>V.</given-names>
<surname>Grum-Tokars</surname>
</string-name>, <string-name>
<given-names>D. C.</given-names>
<surname>Mulhearn</surname>
</string-name>, <string-name>
<given-names>S. C.</given-names>
<surname>Baker</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Coughlin</surname>
</string-name>, <string-name>
<given-names>B. S.</given-names>
<surname>Prabhakar</surname>
</string-name>, <string-name>
<given-names>K.</given-names>
<surname>Sleeman</surname>
</string-name>, <string-name>
<given-names>M. E.</given-names>
<surname>Johnson</surname>
</string-name>, <string-name>
<given-names>A. D.</given-names>
<surname>Mesecar</surname>
</string-name>, <source xml:lang="en">Bioorg. Med. Chem. Lett.</source>
<year>2008</year>, <volume>18</volume>, <fpage>5684</fpage>&#x02013;<lpage>5688</lpage>.<pub-id pub-id-type="pmid">18796354</pub-id></mixed-citation></ref><ref id="minf202000028-bib-0023"><label>23</label><mixed-citation publication-type="journal" id="minf202000028-cit-0023">
<string-name>
<given-names>T.</given-names>
<surname>Pillaiyar</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Manickam</surname>
</string-name>, <string-name>
<given-names>V.</given-names>
<surname>Namasivayam</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Hayashi</surname>
</string-name>, <string-name>
<given-names>S.-H.</given-names>
<surname>Jung</surname>
</string-name>, <source xml:lang="en">J. Med. Chem.</source>
<year>2016</year>, <volume>59</volume>, <fpage>6595</fpage>&#x02013;<lpage>6628</lpage>.<pub-id pub-id-type="pmid">26878082</pub-id></mixed-citation></ref><ref id="minf202000028-bib-0024"><label>24</label><mixed-citation publication-type="miscellaneous" id="minf202000028-cit-0024">Y. Li, J. Zhang, N. Wang, H. Li, Y. Shi, G. Guo, K. Liu, H. Zeng, Q. Zou, <italic>bioRxiv</italic>
<bold>2020</bold>, 2020.01.28.922922.</mixed-citation></ref><ref id="minf202000028-bib-0025"><label>25</label><mixed-citation publication-type="miscellaneous" id="minf202000028-cit-0025">Z. Xu, C. Peng, Y. Shi, Z. Zhu, K. Mu, X. Wang, W. Zhu, <italic>bioRxiv</italic>
<bold>2020</bold>, 2020.01.27.921627.</mixed-citation></ref><ref id="minf202000028-bib-0026"><label>26</label><mixed-citation publication-type="miscellaneous" id="minf202000028-cit-0026">X. Liu, X.-J. Wang, <italic>bioRxiv</italic>
<bold>2020</bold>, 2020.01.29.924100.</mixed-citation></ref><ref id="minf202000028-bib-0027"><label>27</label><mixed-citation publication-type="miscellaneous" id="minf202000028-cit-0027">A. Zhavoronkov, V. Aladinskiy, A. Zhebrak, B. Zagribelnyy, V. Terentiev, D.&#x02005;S. Bezrukov, D. Polykovskiy, R. Shayakhmetov, A. Filimonov, P. Orekhov, Y. Yan, O. Popova, Q. Vanhaelen, A. Aliper, Y. Ivanenkov, <bold>2020</bold>, DOI 10.26434/CHEMRXIV.11829102.V1.</mixed-citation></ref><ref id="minf202000028-bib-0028"><label>28</label><mixed-citation publication-type="miscellaneous" id="minf202000028-cit-0028">H. Zhang, K.&#x02005;M. Saravanan, Y. Yang, Md. T. Hossain, J. Li, X. Ren, Y. Wei, <italic>Deep Learning Based Drug Screening for Novel Coronavirus 2019-NCov</italic>, Other, <bold>2020</bold>.</mixed-citation></ref><ref id="minf202000028-bib-0029"><label>29</label><mixed-citation publication-type="journal" id="minf202000028-cit-0029">
<string-name>
<given-names>A.</given-names>
<surname>Abuhammad</surname>
</string-name>, <string-name>
<given-names>R. A.</given-names>
<surname>Al-Aqtash</surname>
</string-name>, <string-name>
<given-names>B. J.</given-names>
<surname>Anson</surname>
</string-name>, <string-name>
<given-names>A. D.</given-names>
<surname>Mesecar</surname>
</string-name>, <string-name>
<given-names>M. O.</given-names>
<surname>Taha</surname>
</string-name>, <source xml:lang="en">J. Mol. Recognit.</source>
<year>2017</year>, <volume>30</volume>, <elocation-id>e2644</elocation-id>.</mixed-citation></ref><ref id="minf202000028-bib-0030"><label>30</label><mixed-citation publication-type="journal" id="minf202000028-cit-0030">
<string-name>
<given-names>M.</given-names>
<surname>Berry</surname>
</string-name>, <string-name>
<given-names>B.</given-names>
<surname>Fielding</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Gamieldien</surname>
</string-name>, <source xml:lang="en">Viruses</source>
<year>2015</year>, <volume>7</volume>, <fpage>6642</fpage>&#x02013;<lpage>6660</lpage>.<pub-id pub-id-type="pmid">26694449</pub-id></mixed-citation></ref><ref id="minf202000028-bib-0031"><label>31</label><mixed-citation publication-type="journal" id="minf202000028-cit-0031">
<string-name>
<given-names>J.</given-names>
<surname>Lyu</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Wang</surname>
</string-name>, <string-name>
<given-names>T. E.</given-names>
<surname>Balius</surname>
</string-name>, <string-name>
<given-names>I.</given-names>
<surname>Singh</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Levit</surname>
</string-name>, <string-name>
<given-names>Y. S.</given-names>
<surname>Moroz</surname>
</string-name>, <string-name>
<given-names>M. J.</given-names>
<surname>O'Meara</surname>
</string-name>, <string-name>
<given-names>T.</given-names>
<surname>Che</surname>
</string-name>, <string-name>
<given-names>E.</given-names>
<surname>Algaa</surname>
</string-name>, <string-name>
<given-names>K.</given-names>
<surname>Tolmachova</surname>
</string-name>, <string-name>
<given-names>A. A.</given-names>
<surname>Tolmachev</surname>
</string-name>, <string-name>
<given-names>B. K.</given-names>
<surname>Shoichet</surname>
</string-name>, <string-name>
<given-names>B. L.</given-names>
<surname>Roth</surname>
</string-name>, <string-name>
<given-names>J. J.</given-names>
<surname>Irwin</surname>
</string-name>, <source xml:lang="en">Nature</source>
<year>2019</year>, <volume>566</volume>, <fpage>224</fpage>&#x02013;<lpage>229</lpage>.<pub-id pub-id-type="pmid">30728502</pub-id></mixed-citation></ref><ref id="minf202000028-bib-0032"><label>32</label><mixed-citation publication-type="journal" id="minf202000028-cit-0032">
<string-name>
<given-names>H.</given-names>
<surname>Zhang</surname>
</string-name>, <string-name>
<given-names>L.</given-names>
<surname>Liao</surname>
</string-name>, <string-name>
<given-names>K. M.</given-names>
<surname>Saravanan</surname>
</string-name>, <string-name>
<given-names>P.</given-names>
<surname>Yin</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Wei</surname>
</string-name>, <source xml:lang="en">PeerJ</source>
<year>2019</year>, <volume>7</volume>, <elocation-id>e7362</elocation-id>.<pub-id pub-id-type="pmid">31380152</pub-id></mixed-citation></ref><ref id="minf202000028-bib-0033"><label>33</label><mixed-citation publication-type="journal" id="minf202000028-cit-0033">
<string-name>
<given-names>P. H. M.</given-names>
<surname>Torres</surname>
</string-name>, <string-name>
<given-names>A. C. R.</given-names>
<surname>Sodero</surname>
</string-name>, <string-name>
<given-names>P.</given-names>
<surname>Jofily</surname>
</string-name>, <string-name>
<given-names>F. P.</given-names>
<surname>Silva</surname>&#x02005;
<suffix>Jr</suffix>
</string-name>, <source xml:lang="en">IJMS</source>
<year>2019</year>, <volume>20</volume>, <fpage>4574</fpage>.</mixed-citation></ref><ref id="minf202000028-bib-0034"><label>34</label><mixed-citation publication-type="journal" id="minf202000028-cit-0034">
<string-name>
<given-names>M.</given-names>
<surname>Ragoza</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Hochuli</surname>
</string-name>, <string-name>
<given-names>E.</given-names>
<surname>Idrobo</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Sunseri</surname>
</string-name>, <string-name>
<given-names>D. R.</given-names>
<surname>Koes</surname>
</string-name>, <source xml:lang="en">J. Chem. Inf. Model.</source>
<year>2017</year>, <volume>57</volume>, <fpage>942</fpage>&#x02013;<lpage>957</lpage>.<pub-id pub-id-type="pmid">28368587</pub-id></mixed-citation></ref><ref id="minf202000028-bib-0035"><label>35</label><mixed-citation publication-type="journal" id="minf202000028-cit-0035">
<string-name>
<given-names>H. M.</given-names>
<surname>Ashtawy</surname>
</string-name>, <string-name>
<given-names>N. R.</given-names>
<surname>Mahapatra</surname>
</string-name>, <source xml:lang="en">IEEE/ACM Trans. Comput. Biol. Bioinf.</source>
<year>2015</year>, <volume>12</volume>, <fpage>335</fpage>&#x02013;<lpage>347</lpage>.</mixed-citation></ref><ref id="minf202000028-bib-0036"><label>36</label><mixed-citation publication-type="journal" id="minf202000028-cit-0036">
<string-name>
<given-names>R. A.</given-names>
<surname>Friesner</surname>
</string-name>, <string-name>
<given-names>J. L.</given-names>
<surname>Banks</surname>
</string-name>, <string-name>
<given-names>R. B.</given-names>
<surname>Murphy</surname>
</string-name>, <string-name>
<given-names>T. A.</given-names>
<surname>Halgren</surname>
</string-name>, <string-name>
<given-names>J. J.</given-names>
<surname>Klicic</surname>
</string-name>, <string-name>
<given-names>D. T.</given-names>
<surname>Mainz</surname>
</string-name>, <string-name>
<given-names>M. P.</given-names>
<surname>Repasky</surname>
</string-name>, <string-name>
<given-names>E. H.</given-names>
<surname>Knoll</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Shelley</surname>
</string-name>, <string-name>
<given-names>J. K.</given-names>
<surname>Perry</surname>
</string-name>, <string-name>
<given-names>D. E.</given-names>
<surname>Shaw</surname>
</string-name>, <string-name>
<given-names>P.</given-names>
<surname>Francis</surname>
</string-name>, <string-name>
<given-names>P. S.</given-names>
<surname>Shenkin</surname>
</string-name>, <source xml:lang="en">J. Med. Chem.</source>
<year>2004</year>, <volume>47</volume>, <fpage>1739</fpage>&#x02013;<lpage>49</lpage>.<pub-id pub-id-type="pmid">15027865</pub-id></mixed-citation></ref><ref id="minf202000028-bib-0037"><label>37</label><mixed-citation publication-type="journal" id="minf202000028-cit-0037">
<string-name>
<given-names>T.</given-names>
<surname>Pillaiyar</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Manickam</surname>
</string-name>, <string-name>
<given-names>V.</given-names>
<surname>Namasivayam</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Hayashi</surname>
</string-name>, <string-name>
<given-names>S.-H.</given-names>
<surname>Jung</surname>
</string-name>, <source xml:lang="en">J. Med. Chem.</source>
<year>2016</year>, <volume>59</volume>, <fpage>6595</fpage>&#x02013;<lpage>6628</lpage>.<pub-id pub-id-type="pmid">26878082</pub-id></mixed-citation></ref><ref id="minf202000028-bib-0038"><label>38</label><mixed-citation publication-type="journal" id="minf202000028-cit-0038">
<string-name>
<given-names>M.</given-names>
<surname>Turlington</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Chun</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Tomar</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Eggler</surname>
</string-name>, <string-name>
<given-names>V.</given-names>
<surname>Grum-Tokars</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Jacobs</surname>
</string-name>, <string-name>
<given-names>J. S.</given-names>
<surname>Daniels</surname>
</string-name>, <string-name>
<given-names>E.</given-names>
<surname>Dawson</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Saldanha</surname>
</string-name>, <string-name>
<given-names>P.</given-names>
<surname>Chase</surname>
</string-name>, <string-name>
<given-names>Y. M.</given-names>
<surname>Baez-Santos</surname>
</string-name>, <string-name>
<given-names>C. W.</given-names>
<surname>Lindsley</surname>
</string-name>, <string-name>
<given-names>P.</given-names>
<surname>Hodder</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Mesecar</surname>
</string-name>, <string-name>
<given-names>S. R.</given-names>
<surname>Stauffer</surname>
</string-name>, <source xml:lang="en">Bioorg. Med. Chem. Lett.</source>
<year>2013</year>, <volume>23</volume>, <fpage>6172</fpage>&#x02013;<lpage>6177</lpage>.<pub-id pub-id-type="pmid">24080461</pub-id></mixed-citation></ref><ref id="minf202000028-bib-0039"><label>39</label><mixed-citation publication-type="journal" id="minf202000028-cit-0039">
<string-name>
<given-names>M. M.</given-names>
<surname>Mysinger</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Carchia</surname>
</string-name>, <string-name>
<given-names>J. J.</given-names>
<surname>Irwin</surname>
</string-name>, <string-name>
<given-names>B. K.</given-names>
<surname>Shoichet</surname>
</string-name>, <source xml:lang="en">J. Med. Chem.</source>
<year>2012</year>, <volume>55</volume>, <fpage>6582</fpage>&#x02013;<lpage>6594</lpage>.<pub-id pub-id-type="pmid">22716043</pub-id></mixed-citation></ref><ref id="minf202000028-bib-0040"><label>40</label><mixed-citation publication-type="miscellaneous" id="minf202000028-cit-0040">OpenEye Scientific Software, <bold>2019</bold>.</mixed-citation></ref><ref id="minf202000028-bib-0041"><label>41</label><mixed-citation publication-type="journal" id="minf202000028-cit-0041">
<string-name>
<given-names>P. C. D.</given-names>
<surname>Hawkins</surname>
</string-name>, <string-name>
<given-names>A. G.</given-names>
<surname>Skillman</surname>
</string-name>, <string-name>
<given-names>G. L.</given-names>
<surname>Warren</surname>
</string-name>, <string-name>
<given-names>B. A.</given-names>
<surname>Ellingson</surname>
</string-name>, <string-name>
<given-names>M. T.</given-names>
<surname>Stahl</surname>
</string-name>, <source xml:lang="en">J. Chem. Inf. Model.</source>
<year>2010</year>, <volume>50</volume>, <fpage>572</fpage>&#x02013;<lpage>584</lpage>.<pub-id pub-id-type="pmid">20235588</pub-id></mixed-citation></ref><ref id="minf202000028-bib-0042"><label>42</label><mixed-citation publication-type="journal" id="minf202000028-cit-0042">
<string-name>
<given-names>H. M.</given-names>
<surname>Berman</surname>
</string-name>, <source xml:lang="en">Nucleic Acids Res.</source>
<year>2000</year>, <volume>28</volume>, <fpage>235</fpage>&#x02013;<lpage>242</lpage>.<pub-id pub-id-type="pmid">10592235</pub-id></mixed-citation></ref><ref id="minf202000028-bib-0043"><label>43</label><mixed-citation publication-type="miscellaneous" id="minf202000028-cit-0043">Schr&#x000f6;dinger LLC, <bold>2019</bold>.</mixed-citation></ref><ref id="minf202000028-bib-0044"><label>44</label><mixed-citation publication-type="journal" id="minf202000028-cit-0044">
<string-name>
<given-names>T.</given-names>
<surname>Sterling</surname>
</string-name>, <string-name>
<given-names>J. J.</given-names>
<surname>Irwin</surname>
</string-name>, <source xml:lang="en">J. Chem. Inf. Model.</source>
<year>2015</year>, <volume>55</volume>, <fpage>2324</fpage>&#x02013;<lpage>2337</lpage>.<pub-id pub-id-type="pmid">26479676</pub-id></mixed-citation></ref><ref id="minf202000028-bib-0045"><label>45</label><mixed-citation publication-type="miscellaneous" id="minf202000028-cit-0045">X. Liu, B. Zhang, Z. Jin, H. Yang, Z. Rao, <italic>RCSB Protein Data Bank</italic>
<bold>2020</bold>, DOI 10.2210/PDB6LU7/PDB.</mixed-citation></ref><ref id="minf202000028-bib-0046"><label>46</label><mixed-citation publication-type="journal" id="minf202000028-cit-0046">
<string-name>
<given-names>T.</given-names>
<surname>Liu</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Lin</surname>
</string-name>, <string-name>
<given-names>X.</given-names>
<surname>Wen</surname>
</string-name>, <string-name>
<given-names>R. N.</given-names>
<surname>Jorissen</surname>
</string-name>, <string-name>
<given-names>M. K.</given-names>
<surname>Gilson</surname>
</string-name>, <source xml:lang="en">Nucleic Acids Res.</source>
<year>2007</year>, <volume>35</volume>, D<fpage>198</fpage>&#x02013;D<lpage>201</lpage>.</mixed-citation></ref><ref id="minf202000028-bib-0047"><label>47</label><mixed-citation publication-type="miscellaneous" id="minf202000028-cit-0047">Z. Jin, X. Du, Y. Xu, Y. Deng, M. Liu, Y. Zhao, B. Zhang, X. Li, L. Zhang, Y. Duan, J. Yu, L. Wang, K. Yang, F. Liu, T. You, X. Liu, X. Yang, F. Bai1, H. Liu, X. Liu, L.&#x02005;W. Guddat, G. Xiao, C. Qin, Z. Shi, H. Jiang, Z. Rao, H. Yang, <italic>bioRxiv</italic>
<bold>2020</bold>, DOI 10.1101/2020.02.26.964882.</mixed-citation></ref><ref id="minf202000028-bib-0048"><label>48</label><mixed-citation publication-type="journal" id="minf202000028-cit-0048">
<string-name>
<given-names>F.</given-names>
<surname>Shah</surname>
</string-name>, <string-name>
<given-names>P.</given-names>
<surname>Mukherjee</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Gut</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Legac</surname>
</string-name>, <string-name>
<given-names>P. J.</given-names>
<surname>Rosenthal</surname>
</string-name>, <string-name>
<given-names>B. L.</given-names>
<surname>Tekwani</surname>
</string-name>, <string-name>
<given-names>M. A.</given-names>
<surname>Avery</surname>
</string-name>, <source xml:lang="en">J. Chem. Inf. Model.</source>
<year>2011</year>, <volume>51</volume>, <fpage>852</fpage>&#x02013;<lpage>864</lpage>.<pub-id pub-id-type="pmid">21428453</pub-id></mixed-citation></ref><ref id="minf202000028-bib-0049"><label>49</label><mixed-citation publication-type="journal" id="minf202000028-cit-0049">
<string-name>
<given-names>P. K.</given-names>
<surname>Das</surname>
</string-name>, <string-name>
<given-names>L.</given-names>
<surname>Puusepp</surname>
</string-name>, <string-name>
<given-names>F. S.</given-names>
<surname>Varghese</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Utt</surname>
</string-name>, <string-name>
<given-names>T.</given-names>
<surname>Ahola</surname>
</string-name>, <string-name>
<given-names>D. G.</given-names>
<surname>Kananovich</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Lopp</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Merits</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Karelson</surname>
</string-name>, <source xml:lang="en">Antimicrob. Agents Chemother.</source>
<year>2016</year>, <volume>60</volume>, <fpage>7382</fpage>&#x02013;<lpage>7395</lpage>.<pub-id pub-id-type="pmid">27736770</pub-id></mixed-citation></ref><ref id="minf202000028-bib-0050"><label>50</label><mixed-citation publication-type="journal" id="minf202000028-cit-0050">
<string-name>
<given-names>N. S.</given-names>
<surname>Pagadala</surname>
</string-name>, <string-name>
<given-names>K.</given-names>
<surname>Syed</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Tuszynski</surname>
</string-name>, <source xml:lang="en">Biophys. Rev. Lett.</source>
<year>2017</year>, <volume>9</volume>, <fpage>91</fpage>&#x02013;<lpage>102</lpage>.</mixed-citation></ref><ref id="minf202000028-bib-0051"><label>51</label><mixed-citation publication-type="journal" id="minf202000028-cit-0051">
<string-name>
<given-names>L.</given-names>
<surname>Chaput</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Martinez-Sanz</surname>
</string-name>, <string-name>
<given-names>N.</given-names>
<surname>Saettel</surname>
</string-name>, <string-name>
<given-names>L.</given-names>
<surname>Mouawad</surname>
</string-name>, <source xml:lang="en">J. Cheminf.</source>
<year>2016</year>, <volume>8</volume>, <fpage>56</fpage>.</mixed-citation></ref><ref id="minf202000028-bib-0052"><label>52</label><mixed-citation publication-type="miscellaneous" id="minf202000028-cit-0052">F. Gentile, V. Agrawal, M. Hsing, F. Ban, U. Norinder, M.&#x02005;E. Gleave, A. Cherkasov, <italic>bioRxiv</italic>
<bold>2019</bold>, 2019.12.15.877316.</mixed-citation></ref><ref id="minf202000028-bib-0053"><label>53</label><mixed-citation publication-type="journal" id="minf202000028-cit-0053">
<string-name>
<given-names>T.</given-names>
<surname>Muramatsu</surname>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Takemoto</surname>
</string-name>, <string-name>
<given-names>Y.-T.</given-names>
<surname>Kim</surname>
</string-name>, <string-name>
<given-names>H.</given-names>
<surname>Wang</surname>
</string-name>, <string-name>
<given-names>W.</given-names>
<surname>Nishii</surname>
</string-name>, <string-name>
<given-names>T.</given-names>
<surname>Terada</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Shirouzu</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Yokoyama</surname>
</string-name>, <source xml:lang="en">Proc. Natl. Acad. Sci. USA</source>
<year>2016</year>, <volume>113</volume>, <fpage>12997</fpage>&#x02013;<lpage>13002</lpage>.<pub-id pub-id-type="pmid">27799534</pub-id></mixed-citation></ref><ref id="minf202000028-bib-0054"><label>54</label><mixed-citation publication-type="journal" id="minf202000028-cit-0054">
<string-name>
<given-names>L.</given-names>
<surname>Kiemer</surname>
</string-name>, <string-name>
<given-names>O.</given-names>
<surname>Lund</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Brunak</surname>
</string-name>, <string-name>
<given-names>N.</given-names>
<surname>Blom</surname>
</string-name>, <source xml:lang="en">BMC Bioinf.</source>
<year>2004</year>, <volume>5</volume>, <fpage>72</fpage>.</mixed-citation></ref><ref id="minf202000028-bib-0055"><label>55</label><mixed-citation publication-type="journal" id="minf202000028-cit-0055">
<string-name>
<given-names>J. E.</given-names>
<surname>Blanchard</surname>
</string-name>, <string-name>
<given-names>N. H.</given-names>
<surname>Elowe</surname>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Huitema</surname>
</string-name>, <string-name>
<given-names>P. D.</given-names>
<surname>Fortin</surname>
</string-name>, <string-name>
<given-names>J. D.</given-names>
<surname>Cechetto</surname>
</string-name>, <string-name>
<given-names>L. D.</given-names>
<surname>Eltis</surname>
</string-name>, <string-name>
<given-names>E. D.</given-names>
<surname>Brown</surname>
</string-name>, <source xml:lang="en">Chem. Biol.</source>
<year>2004</year>, <volume>11</volume>, <fpage>1445</fpage>&#x02013;<lpage>1453</lpage>.<pub-id pub-id-type="pmid">15489171</pub-id></mixed-citation></ref><ref id="minf202000028-bib-0056"><label>56</label><mixed-citation publication-type="journal" id="minf202000028-cit-0056">
<string-name>
<given-names>K.</given-names>
<surname>Anand</surname>
</string-name>, <source xml:lang="en">Science</source>
<year>2003</year>, <volume>300</volume>, <fpage>1763</fpage>&#x02013;<lpage>1767</lpage>.<pub-id pub-id-type="pmid">12746549</pub-id></mixed-citation></ref><ref id="minf202000028-bib-0057"><label>57</label><mixed-citation publication-type="journal" id="minf202000028-cit-0057">
<string-name>
<given-names>H.</given-names>
<surname>Yang</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Yang</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Ding</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Liu</surname>
</string-name>, <string-name>
<given-names>Z.</given-names>
<surname>Lou</surname>
</string-name>, <string-name>
<given-names>Z.</given-names>
<surname>Zhou</surname>
</string-name>, <string-name>
<given-names>L.</given-names>
<surname>Sun</surname>
</string-name>, <string-name>
<given-names>L.</given-names>
<surname>Mo</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Ye</surname>
</string-name>, <string-name>
<given-names>H.</given-names>
<surname>Pang</surname>
</string-name>, <string-name>
<given-names>G. F.</given-names>
<surname>Gao</surname>
</string-name>, <string-name>
<given-names>K.</given-names>
<surname>Anand</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Bartlam</surname>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Hilgenfeld</surname>
</string-name>, <string-name>
<given-names>Z.</given-names>
<surname>Rao</surname>
</string-name>, <source xml:lang="en">Proc. Natl. Acad. Sci. USA</source>
<year>2003</year>, <volume>100</volume>, <fpage>13190</fpage>&#x02013;<lpage>13195</lpage>.<pub-id pub-id-type="pmid">14585926</pub-id></mixed-citation></ref><ref id="minf202000028-bib-0058"><label>58</label><mixed-citation publication-type="journal" id="minf202000028-cit-0058">
<string-name>
<given-names>G. W.</given-names>
<surname>Bemis</surname>
</string-name>, <string-name>
<given-names>M. A.</given-names>
<surname>Murcko</surname>
</string-name>, <source xml:lang="en">J. Med. Chem.</source>
<year>1996</year>, <volume>39</volume>, <fpage>2887</fpage>&#x02013;<lpage>2893</lpage>.<pub-id pub-id-type="pmid">8709122</pub-id></mixed-citation></ref></ref-list></back></article>